News

Tensions mount across the European pharmaceutical scene over the fate of the EMA with just weeks before the final decision is going to be made on where it will be moved to.

An RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.

With several systems existing to measure performance, the most significant are the course of patient recruitment, how many patients complete the study, as well as the quality of the data generated.

ZS Associates specify the four pillars of patient centricity that can help the demands and complexities of clinical trials.

The use of Natural History studies in order to examine a rare disease that will help facilitate drug development programs.

FDA advisory committee made up of patients comes together to improve clinical trials and product development through better study design and greater participation.

Updated employee announcements, business news, awards, and recognition in the industry today.